• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Levetiracetam exposure in utero not associated with neurodevelopmental delays

bys25qthea
January 12, 2014
in Chronic Disease, Obstetrics
Reading Time: 3 mins read
Antepartum and intrapartum events both linked to neonatal HIE
Share on FacebookShare on Twitter

Image: PD

1. Exposure to levetiracetam in utero was not associated with increased developmental or language delays in children at ages 3-4.5 years.

2. Children exposed to valproic acid in utero scored lower on gross motor, comprehension and language skill assessments at 3-4.5 years compared to those exposed to levetiracetam.

Evidence Rating Level: 2 (Good)

Study Rundown: This study found that exposure to levetiracetam, an anti-epileptic drug, in utero was not associated with developmental or language delays in preschool aged children but that valproic acid was associated with delays. This is one of the first studies to look at the long-term effects of in utero levetiracetam exposure.

A limitation of the current study is the difference in the prevalence of pregnant mothers on levetiracetam (83%) versus valproic acid (35%). Additionally, seizure exposure in utero was not reported in the initial prospective database and had to be collected retrospectively. Future studies might try to replicate results in a prospective, inception cohort that controls for type, frequency, and duration of seizures to better separate the long term effects of seizure and anti-epileptic exposure in utero.

RELATED REPORTS

Levetiracetam not clinically effective nor cost-effective compared to valproate for newly diagnosed generalized or unclassified epilepsy

Lamotrigine offers higher net health benefits and is more cost-effective than levetiracetam and zonisamide as first-line focal epilepsy treatment

Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy

Click to read the study in Neurology

Click to read an accompanying editorial in Neurology

Relevant Reading: Comparative safety of antiepileptic drugs during pregnancy

In-Depth [prospective observational study]: Researchers recruited children ages 36-54 months born to women with epilepsy who used either levetiracetam (Keppra) (n=53) or valproic acid (Depakote) (n=44) from a prospective UK register. Children born to women without epilepsy who did not take medication, controls, (n=131) were recruited from a separate database. Children were assessed for cognitive and language development using the Griffiths Mental Development Scales (GMDS) and the Reynell Language Development Scale (RLDS) respectively.

Children exposed to levetiracetam in utero did not differ in cognitive or language development skills compared with controls. On average, children exposed to valproic acid scored 15.8 points lower on gross motor skills (p<0.001), 6.4 points lower on language comprehension (p=0.005), and 9.5 points lower on language expression (p<0.001) than children exposed to levetiracetam. Maternal seizures during pregnancy were associated with lower scores on all cognitive and the majority of language assessments.

By Maren Shapiro and Leah Hawkins, MD, MPH

More from this author: IUD contraception equally safe in teenagers as in older women, Black men less likely to receive follow-up for elevated prostate cancer marker, PSA, Intake of fish fatty acids associated with lower risk of breast cancer, USPSTF recommends chemoprevention for women at high risk for breast cancer, Insurance status affects treatment of early stage breast cancer, SERMs decrease breast cancer risk even after treatment

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: Levetiracetam
Previous Post

Preperitoneal mesh placement a valid option for ventral hernia repair

Next Post

Proper passenger restraint use linked to parental race

RelatedReports

Combined MRI and NIH stroke scores may predict stroke prognosis
Neurology

Levetiracetam not clinically effective nor cost-effective compared to valproate for newly diagnosed generalized or unclassified epilepsy

June 25, 2021
Combined MRI and NIH stroke scores may predict stroke prognosis
Chronic Disease

Lamotrigine offers higher net health benefits and is more cost-effective than levetiracetam and zonisamide as first-line focal epilepsy treatment

April 30, 2021
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Chronic Disease

Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy

February 4, 2020
Weekly Rewinds

2 Minute Medicine Rewind January 6, 2020

February 3, 2020
Next Post
Proper passenger restraint use linked to parental race

Proper passenger restraint use linked to parental race

Intentional injuries leading to ED visits often occur at school

Intentional injuries leading to ED visits often occur at school

Smokeless tobacco use in children has not changed

2 Minute Medicine Rewind January 6-12, 2014

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Deficits in executive function are not universal among patients with alcohol use disorder
  • Choice of bicarbonate-buffered solution versus compound sodium lactate as the intraoperative crystalloid solution during abdominal surgery remains unclear
  • Artificial intelligence (AI)-based coronary calcium quantification successfully identified patients who could benefit from lipid-lowering therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.